News and Trends 12 Aug 2021
European Biotechs Fire up Deals to Develop Parkinson’s Treatments
Last month, European biotechs Ipsen and AC Immune announced multi-million euro deals to acquire or license treatments for Parkinson's disease. For some experts, this increasing interest in the brain disease…